Thursday, June 25, 2015 1:18:55 PM
Tweed will be able to access all the data from BED's ongoing 8 clinical trials, and 20 completed clinical trials. BED was investigating oils/extracts in Europe years ago, and have many R&D projects on the side regarding precise dosage THC inhalers that can only work with BED product as they are the only one that can gaurantee a consistant THC/CBD dosage per single bud.
What Tweed needs to do inhouse testing is the HC "Dealers" licence to be approved so they can begin extracting with the 9 months of trimmings they have saved. They are first in line and front of the queue for this.
What Tweed needs to do inhouse testing is the HC "Dealers" licence to be approved so they can begin extracting with the 9 months of trimmings they have saved. They are first in line and front of the queue for this.
Recent WEED News
- Canopy Growth Launches Deep Space Infused Pre-Rolls • Business Wire • 07/10/2025 11:30:00 AM
- Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer • Business Wire • 07/09/2025 12:55:00 PM
- Storz & Bickel Named “Equipment Provider of the Year” at Business of Cannabis Awards 2025 • Business Wire • 07/08/2025 11:30:00 AM
- Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results • Business Wire • 05/30/2025 11:00:00 AM
- Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025 • Business Wire • 05/16/2025 11:30:00 AM
- Canopy Growth Drives Innovation in High-Demand Segments With Latest Product Launches • Business Wire • 05/06/2025 11:30:00 AM
